Annual CFF
$45.49 M
+$44.34 M+3865.91%
31 December 2023
Summary:
C4 Therapeutics annual cash flow from financing activities is currently $45.49 million, with the most recent change of +$44.34 million (+3865.91%) on 31 December 2023. During the last 3 years, it has fallen by -$303.44 million (-86.96%). CCCC annual CFF is now -86.96% below its all-time high of $348.93 million, reached on 31 December 2020.CCCC Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$10.51 M
+$10.37 M+7682.22%
30 September 2024
Summary:
C4 Therapeutics quarterly cash flow from financing activities is currently $10.51 million, with the most recent change of +$10.37 million (+7682.22%) on 30 September 2024. Over the past year, it has increased by +$21.26 million (+197.70%). CCCC quarterly CFF is now -94.59% below its all-time high of $194.05 million, reached on 31 December 2020.CCCC Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$102.90 M
+$21.26 M+26.04%
30 September 2024
Summary:
C4 Therapeutics TTM cash flow from financing activities is currently $102.90 million, with the most recent change of +$21.26 million (+26.04%) on 30 September 2024. Over the past year, it has increased by +$115.03 million (+947.86%). CCCC TTM CFF is now -71.96% below its all-time high of $366.90 million, reached on 30 June 2021.CCCC TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3865.9% | +197.7% | +947.9% |
| 3 y3 years | -87.0% | +1699.0% | -71.8% |
| 5 y5 years | +2219.7% | - | - |
CCCC Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -87.0% | +3865.9% | -81.8% | +197.7% | -71.8% | +947.9% |
| 5 y | 5 years | -87.0% | >+9999.0% | -94.6% | +197.7% | -72.0% | +947.9% |
| alltime | all time | -87.0% | >+9999.0% | -94.6% | +197.7% | -72.0% | +947.9% |
C4 Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $10.51 M(+7682.2%) | $102.90 M(+26.0%) |
| June 2024 | - | $135.00 K(-99.6%) | $81.64 M(+1.1%) |
| Mar 2024 | - | $34.58 M(-40.0%) | $80.76 M(+77.5%) |
| Dec 2023 | $45.49 M(+3865.9%) | $57.67 M(-636.3%) | $45.49 M(-474.8%) |
| Sept 2023 | - | -$10.75 M(+1341.4%) | -$12.14 M(+1087.5%) |
| June 2023 | - | -$746.00 K(+9.1%) | -$1.02 M(+5911.8%) |
| Mar 2023 | - | -$684.00 K(-1555.3%) | -$17.00 K(-101.5%) |
| Dec 2022 | $1.15 M | $47.00 K(-87.0%) | $1.15 M(-26.8%) |
| Sept 2022 | - | $361.00 K(+39.4%) | $1.57 M(-12.5%) |
| June 2022 | - | $259.00 K(-46.0%) | $1.79 M(-99.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $480.00 K(+3.0%) | $172.03 M(+0.4%) |
| Dec 2021 | $171.40 M(-50.9%) | $466.00 K(-20.2%) | $171.40 M(-53.0%) |
| Sept 2021 | - | $584.00 K(-99.7%) | $364.99 M(-0.5%) |
| June 2021 | - | $170.50 M(<-9900.0%) | $366.90 M(+5.2%) |
| Mar 2021 | - | -$151.00 K(-100.1%) | $348.63 M(-0.1%) |
| Dec 2020 | $348.93 M(>+9900.0%) | $194.05 M(+7665.2%) | $348.93 M(+125.3%) |
| Sept 2020 | - | $2.50 M(-98.4%) | $154.88 M(+1.6%) |
| June 2020 | - | $152.22 M(>+9900.0%) | $152.38 M(>+9900.0%) |
| Mar 2020 | - | $156.00 K | $156.00 K |
| Dec 2019 | $244.00 K(-87.6%) | - | - |
| Dec 2018 | $1.96 M | - | - |
FAQ
- What is C4 Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for C4 Therapeutics?
- What is C4 Therapeutics annual CFF year-on-year change?
- What is C4 Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for C4 Therapeutics?
- What is C4 Therapeutics quarterly CFF year-on-year change?
- What is C4 Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for C4 Therapeutics?
- What is C4 Therapeutics TTM CFF year-on-year change?
What is C4 Therapeutics annual cash flow from financing activities?
The current annual CFF of CCCC is $45.49 M
What is the all time high annual CFF for C4 Therapeutics?
C4 Therapeutics all-time high annual cash flow from financing activities is $348.93 M
What is C4 Therapeutics annual CFF year-on-year change?
Over the past year, CCCC annual cash flow from financing activities has changed by +$44.34 M (+3865.91%)
What is C4 Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of CCCC is $10.51 M
What is the all time high quarterly CFF for C4 Therapeutics?
C4 Therapeutics all-time high quarterly cash flow from financing activities is $194.05 M
What is C4 Therapeutics quarterly CFF year-on-year change?
Over the past year, CCCC quarterly cash flow from financing activities has changed by +$21.26 M (+197.70%)
What is C4 Therapeutics TTM cash flow from financing activities?
The current TTM CFF of CCCC is $102.90 M
What is the all time high TTM CFF for C4 Therapeutics?
C4 Therapeutics all-time high TTM cash flow from financing activities is $366.90 M
What is C4 Therapeutics TTM CFF year-on-year change?
Over the past year, CCCC TTM cash flow from financing activities has changed by +$115.03 M (+947.86%)